Zhiyuan Zheng

ORCID: 0000-0002-2896-1845
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory Biomarkers in Disease Prognosis
  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Ferroptosis and cancer prognosis
  • Cancer-related molecular mechanisms research
  • Esophageal Cancer Research and Treatment
  • RNA modifications and cancer
  • Gastric Cancer Management and Outcomes

Fujian Medical University
2021

Union Hospital
2021

Fudan University
2019

Zhongshan Hospital
2019

Shanghai Institute of Hematology
2019

Background Ferroptosis is a recently recognized type of programmed cell death that involved in the biological processes various cancers. However, mechanism ferroptosis lung adenocarcinoma (LUAD) remains unclear. This study aimed to determine role ferroptosis-associated long non-coding RNAs (lncRNAs) LUAD and establish prognostic model. Methods We downloaded ferroptosis-related genes from FerrDb database RNA sequencing data clinicopathological characteristics The Cancer Genome Atlas. randomly...

10.3389/fgene.2021.690509 article EN cc-by Frontiers in Genetics 2021-07-22

We retrospectively analyzed the prognostic value of albumin-to-fibrinogen ratio (AFR)-neutrophil-to-lymphocyte (NLR) score, comprising preoperative AFR and NLR, in esophageal squamous cell carcinoma (ESCC) patients after radical resection.Overall, 215 were included. The optimal cutoff was determined using receiver operating characteristic (ROC) curve. Based on a low (<12.06) high NLR (≥1.78), AFR-NLR score classified as 2 (both hematological abnormalities present), 1 (one abnormality or 0...

10.2147/cmar.s296266 article EN cc-by-nc Cancer Management and Research 2021-03-01

To evaluate the safety and efficacy of percutaneous microwave ablation (MWA) combined with simultaneous transarterial chemoembolization (TACE) in patients hepatocellular carcinoma (HCC) microvascular invasion (MVI) or extrahepatic metastases (EHM).Between August 2012 April 2017, 101 MVI/EHM HCC underwent MWA TACE at our center. The clinical data were collected analyzed for survival prognostic factors.The mean follow-up time was 23.6 ± 14.7 months. One patient had grade 3 complications,...

10.1016/j.jimed.2019.07.003 article EN cc-by-nc-nd Journal of interventional medicine 2019-05-01
Coming Soon ...